BridgeBio Pharma (BBIO) Times Interest Earned: 2019-2025
Historic Times Interest Earned for BridgeBio Pharma (BBIO) over the last 7 years, with Sep 2025 value amounting to -$12.37.
- BridgeBio Pharma's Times Interest Earned fell 48.76% to -$12.37 in Q3 2025 from the same period last year, while for Sep 2025 it was -$5.03, marking a year-over-year increase of 17.14%. This contributed to the annual value of -$5.97 for FY2024, which is 20.07% up from last year.
- Latest data reveals that BridgeBio Pharma reported Times Interest Earned of -$12.37 as of Q3 2025, which was down 246.69% from -$3.57 recorded in Q2 2025.
- BridgeBio Pharma's 5-year Times Interest Earned high stood at $0.01 for Q1 2024, and its period low was -$17.20 during Q1 2021.
- For the 3-year period, BridgeBio Pharma's Times Interest Earned averaged around -$6.53, with its median value being -$7.58 (2024).
- In the last 5 years, BridgeBio Pharma's Times Interest Earned spiked by 100.23% in 2024 and then crashed by 17,047.93% in 2025.
- Quarterly analysis of 5 years shows BridgeBio Pharma's Times Interest Earned stood at -$10.94 in 2021, then soared by 40.92% to -$6.46 in 2022, then slumped by 35.40% to -$8.75 in 2023, then increased by 13.41% to -$7.58 in 2024, then slumped by 48.76% to -$12.37 in 2025.
- Its Times Interest Earned was -$12.37 in Q3 2025, compared to -$3.57 in Q2 2025 and -$2.48 in Q1 2025.